OKYO Pharma Limited Result of AGM (6877E)

TIDMOKYO

RNS Number : 6877E

OKYO Pharma Limited

02 March 2020

THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 596/2014

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

OKYO Pharma Limited

("OKYO" or the "Company")

Result of Annual General Meeting

At the Annual General Meeting of the Company held at 10.00 a.m. on 2 March 2020 at the offices of Orrick, Herrington & Sutcliffe (UK) LLP, 107 Cheapside, London, EC2V 6DN, all of the resolutions were duly passed.

The results of the proxy voting will be available shortly on the Company's website, www.okyopharma.com .

The person who arranged for the release of this announcement was Tiziano Lazzaretti, Chief Financial Officer.

About OKYO

OKYO Pharma Limited (LSE: OKYO) is a life sciences and biotechnology company admitted to listing on the standard segment of the Official List of the UK Financial Conduct Authority and to trading on the Main Market for listed securities of the London Stock Exchange plc. OKYO is focusing on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain.

Enquiries:

 
OKYO Pharma Limited              Willy Simon     +44 (0)20 7382 8300 
                                 Antonio Bossi 
Shore Capital Limited (Broker)    David Coaten   +44 (0)20 7601 6100 
                                 --------------  -------------------

For further information, please visit the Company's website at www.okyopharma.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGKKBBBDBKDNNK

(END) Dow Jones Newswires

March 02, 2020 06:50 ET (11:50 GMT)

Okyo Pharma (LSE:OKYO)
Historical Stock Chart
From Apr 2024 to May 2024